No buyers will touch this now unless positive Ph3 Bronchiatasis trial results are released in Q2. I dread to think what the SP will be if Ph3 results fail. Whoever was the suitor in the recent "take over" rumor must be relieved they didn't show their cards. Oh dear!!!!
- Forums
- ASX - By Stock
- SNT
- response letter
response letter, page-24
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
-0.002(4.55%) |
Mkt cap ! $48.95M |
Open | High | Low | Value | Volume |
4.4¢ | 4.4¢ | 4.1¢ | $52.07K | 1.243M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 925000 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 27143 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 925000 | 0.040 |
4 | 319474 | 0.039 |
2 | 280000 | 0.038 |
3 | 652702 | 0.037 |
4 | 700099 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 27143 | 1 |
0.043 | 64740 | 2 |
0.044 | 504458 | 2 |
0.045 | 224000 | 4 |
0.046 | 136000 | 2 |
Last trade - 13.56pm 15/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online